Meloxicam And Diclofenac Do Not Change Vegf And Pdgf-Ab Serum Levels Of Platelet-Rich Plasma
![](/xmlui/themes/Mirage2//images/mime2.png)
View/ Open
Date
2017Author
Utku, Burkay
Donmez, Gurhan
Erisgen, Gulriz
Akin, Senay
Demirel, Haydar Ali
Korkusuz, Feza
Doral, Mahmut Nedim
xmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
Background/aim: Platelet-rich plasma (PRP) application has gained widespread interest for musculoskeletal injuries. Nonsteroidal antiinflammatory drugs are frequently used in sports medicine before and/or after PRP application. Our study seeks to determine whether serum levels of platelet-derived growth factor-AB (PDGF-AB) and vascular endothelial growth factor (VEGF) levels of PRP would be affected by nonsteroidal antiinflammatory drugs. Materials and methods: Two different final concentrations of diclofenac (0.5 mu g mL (1) and 2.5 mu g mL (1)), meloxicam (0.8 mu g mL (1) and 2.0 mu g mL (1)), and acetylsalicylic acid (final concentration 450 mu m) were obtained in separate tubes with PRPs prepared from 20 healthy male volunteers. Medicine-free PRP was the control group. Growth factors were measured using ELISA. Results: PDGF-AB and VEGF serum levels did not change with diclofenac, meloxicam, or acetylsalicylic acid addition. PDGF-AB and VEGF serum levels correlated with each other. Conclusion: Diclofenac, meloxicam, and acetylsalicylic acid did not affect PDGF-AB and VEGF serum levels.